Research graph
References from Cancer and mortality risks among people with multiple sclerosis: A population-based study in Isfahan, Iran. Local targets link to admitted publications; unresolved targets remain external evidence.
Multiple sclerosis–a review
10.1111/ene.13819 · 2019 · External reference
Pediatric multiple sclerosis: a review.
10.1186/s12883-018-1026-3 · 2018 · External reference
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS.
10.1177/1352458520970841 · 2020 · External reference
Multiple sclerosis and cancer in Norway A retrospective cohort study
10.1111/j.1600-0404.1996.tb00019.x · 1996 · External reference
Increasing cancer risk over calendar year in people with multiple sclerosis: a case–control study
10.1007/s00415-020-10170-5 · 2021 · External reference
Cancer risk in patients with multiple sclerosis: potential impact of disease-modifying drugs.
10.1007/s40263-018-0564-y · 2018 · External reference
Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis
10.1177/1352458507083625 · 2008 · External reference
Multiple sclerosis and cancer: the ying-yang effect of disease modifying therapies.
10.3389/fimmu.2019.02954 · 2020 · External reference
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residents.
10.1016/j.msard.2022.103679 · 2022 · External reference
Cancer related mortality in multiple sclerosis. A population based cohort study
10.1016/j.msard.2022.104417 · 2023 · External reference
A systematic review of the incidence and prevalence of cancer in multiple sclerosis
10.1177/1352458514564489 · 2015 · External reference
Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: A population-based study.
10.1016/j.msard.2024.105479 · External reference
An 8-year study of people with multiple sclerosis in Isfahan, Iran: Association between environmental air pollutants and severity of disease
10.1016/j.jneuroim.2018.02.019 · 2018 · External reference
Statistical Centre of Iran
2016 · External reference
Climate change impacts on optimal habitat of Stachys inflata medicinal plant in central Iran.
10.1038/s41598-023-33660-8 · 2023 · External reference
The national multiple sclerosis registry system of Iran (NMSRI): Aspects and methodological dimensions.
10.1016/j.msard.2023.104610 · 2023 · External reference
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
10.1016/s1474-4422(17)30470-2 · 2018 · External reference
Cancer incidence in Iran in 2014: results of the Iranian National Population-based Cancer Registry.
10.1016/j.canep.2019.05.009 · 2019 · External reference
Unresolved reference
2000 · External reference
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
10.1212/wnl.33.11.1444 · 1983 · External reference
Defining the clinical course of multiple sclerosis: results of an international survey
10.1212/wnl.46.4.907 · 1996 · External reference
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
2024 · External reference
Barriers and facilitators related to breast cancer screening: A qualitative study of women with multiple sclerosis.
10.7224/1537-2073-13.2.49 · 2011 · External reference
Association between multiple sclerosis and cancer risk: An extensive review/meta and Mendelian randomization analyses.
2023 · External reference
Risk of cancer in multiple sclerosis (MS): A systematic review and meta-analysis.
10.1016/j.autrev.2020.102650 · 2020 · External reference
Multiple sclerosis and risk of cancer: a meta-analysis
10.1136/jnnp.2009.195776 · 2010 · External reference
Cancer risk and multiple sclerosis: evidence from a large Italian cohort
10.3389/fneur.2019.00337 · 2019 · External reference
Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk
10.1016/j.jns.2016.09.005 · 2016 · External reference
Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran
2017 · External reference
Incidence and risk of cancer among multiple sclerosis patients: A matched population‐based cohort study
10.1111/ene.15226 · 2022 · External reference
Incidence of malignancies in patients with multiple sclerosis versus a healthy matched cohort: A population-based cohort study in the Netherlands using the PHARMO Database Network
10.1016/j.jocn.2022.06.025 · 2022 · External reference
Environmental risk factors for cancer-review paper.
10.26444/aaem/94299 · 2018 · External reference
Genetic predisposition to cancer
10.1016/j.mpmed.2019.11.014 · 2020 · External reference
Impact of lifestyle behaviors on cancer risk and prevention
10.15280/jlm.2021.11.1.1 · 2021 · External reference
Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
10.1136/jnnp-2016-315238 · 2017 · External reference
Global, regional, and national burden of multiple sclerosis from 1990 to 2019: findings of global burden of disease study 2019.
10.3389/fpubh.2023.1073278 · 2023 · External reference
Multiple sclerosis and the cancer diagnosis: diagnostic route, cancer stage, and the diagnostic interval in breast and colorectal cancer
10.1212/wnl.0000000000200163 · 2022 · External reference
Unresolved reference
2022 · External reference
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
2024 · External reference
Concurrent glioma and multiple sclerosis: A systematic review of case reports.
2024 · External reference
Case report: Diagnostic challenge: a new multiple sclerosis “relapse” leading to the diagnosis of anaplastic astrocytoma.
10.3389/fneur.2023.1324269 · 2024 · External reference
Delay in diagnosis of lung cancer in general practice
2006 · External reference
An unusual presentation of metastatic prostate cancer in a 44‐year‐old man: A case report and review of the literature.
10.1002/ccr3.8447 · 2024 · External reference
Incidence of cancer in multiple sclerosis before and after the treatment era–a registry-based cohort study
10.1016/j.msard.2021.103209 · 2021 · External reference
Assessment of cancer risk with β-interferon treatment for multiple sclerosis
10.1136/jnnp-2013-307238 · 2014 · External reference
Impact of immune checkpoint inhibitors on the course of multiple sclerosis
2024 · External reference
Clinical course of multiple sclerosis and patient experiences during breast cancer treatment
10.1177/13524585231175975 · 2023 · External reference
Multiple sclerosis outcomes after cancer immunotherapy
10.1007/s12094-019-02060-8 · 2019 · External reference
The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis.
10.1177/1756286420969501 · 2020 · External reference
